RxDoctor Payments Data

Daniella Ellis

Family · Robinsonville, MSNPI 1528149531

Payments from drug & device makers

$2,115in general payments, 2019–2025

Across 105 payments — averaging $20.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$525
  • Novo Nordisk$398
  • AbbVie$261
  • Bayer$254
  • AstraZeneca$174
  • Abbott$142
  • plus $360 from 11 others

What the payments were for

  • Food & beverage$2,115100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,115 in reported general payments places this provider in the 80th percentile of 3,007 family providers in Mississippi.

See all family providers in Mississippi

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban66$49,270
OzempicSemaglutide39$47,133
BiktarvyBictegrav/Emtricit/Tenofov Ala12$46,107
TrulicityDulaglutide33$37,161
RybelsusSemaglutide28$30,235
JanuviaSitagliptin Phosphate15$18,132
FarxigaDapagliflozin Propanediol11$15,741
XareltoRivaroxaban11$15,016
JardianceEmpagliflozin13$13,992
Breztri AerosphereBudesonide/Glycopyr/Formoterol21$13,411
Semglee (Yfgn) PenInsulin Glargine-Yfgn20$10,429
Combivent RespimatIpratropium/Albuterol Sulfate13$6,283
GemtesaVibegron11$5,032
Levemir FlexpenInsulin Detemir17$3,620
Atorvastatin Calcium270$2,407

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$398$77,36867 claims
PfizerEliquis$25$49,27066 claims
GileadBiktarvy$29$46,10712 claims
Lilly USA, LLCTrulicity$525$37,16133 claims
AstraZenecaFarxiga, Breztri Aerosphere$174$29,15232 claims
Boehringer IngelheimJardiance, Combivent Respimat$15$20,27526 claims
MerckJanuvia$19$18,13215 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,007 family providers in Mississippi.

Other family in Robinsonville

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →